BioSource™, Caltag®, and Zymed® are becoming Invitrogen

Make the most of every cell with Invitrogen Cell Biology: now ISO 13485 Certified

As of Oct. 15, 2008, the mix of products that you recognized as BioSource™ , Caltag®, and Zymed®  now carry the Invitrogen brand.  These products will continue to be manufactured using the same high quality processes and specifications, and are now manufactured under ISO 13485 certification.

Invitrogen continues to deliver world-class tools for Cell Biology– our consolidation of BioSource™, Caltag® and Zymed® means better service for you. You'll get the same trusted, high-quality products and technologies, fortified by Invitrogen's world-class sales, distribution, and product support structure.

If you have any questions please contact your Invitrogen Sales Representative or email our Technical Support department at support@invitrogen.com.

Find Products

You can find BioSource™, Caltag® and Zymed® products in the following application areas of the Invitrogen web site:

About BioSource™

In September 2005, Invitrogen Corporation completed its acquisition of BioSource International.  BioSource™ products include a comprehensive suite of sensitive and specific ELISAs, Luminex® assays, kinase activity assays, recombinant proteins and antibodies for analysis of multiple proteins and pathways. These  proteins include cytokines, growth factors, chemokines, receptor tyrosine kinases (RTKs), Tau, and β-Amyloid.  Pathways include AKT, MAPK ,IκB/NFκB and many more.

About Caltag®

In May 2005 Invitrogen Corporation completed its acquisition of Caltag Laboratories. As a part of Invitrogen, Caltag® products will continue to provide solutions for flow cytometry applications. Caltag® products offer a broad selection of dye conjugates of key himan, mouse and rat markers as well as a wide choice of antibodies to other proteins including cytokines and chemokines.  Caltag® products are widely published and known for high quality.

About ZYMED®

In February 2005 Invitrogen Corporation acquired Zymed® Laboratories and its complete line of immunohistochemistry and in situ hybridization products.  Not only are we still committed to provide the same quality and performance that the Zymed® brand represents but we aim to improve these products by incorporating more efficient processes and procedures.  

Our antibody development team is constantly researching new targets and developing products with proven clinical utilities. Because of its diverse scientific portfolio, Invitrogen is in the unique position of being able to apply “new” methodologies to solve “old” problems in histology and anatomical pathology, such as inconsistent tissue fixation, random tissue pretreatment methods, and poor antigen detection. Enhancing Zymed® immunodetection technologies may help with all of these problems.